Citadel Advisors’s OI S.A. American Depositary Shares, each representing five shares of common stock OIBR.C Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-35,768
Closed -$33K 10634
2019
Q4
$33K Buy
+35,768
New +$39K ﹤0.01% 8848
2019
Q3
Sell
-18,012,030
Closed -$36.2M 10206
2019
Q2
$36.2M Buy
18,012,030
+14,858,647
+471% +$28.2M 0.02% 936
2019
Q1
$5.93M Sell
3,153,383
-14,229,741
-82% -$28M ﹤0.01% 2757
2018
Q4
$27.8M Buy
17,383,124
+1,159,005
+7% +$3.1M 0.02% 980
2018
Q3
$44.3M Buy
+16,224,119
New +$60.9M 0.02% 832
2014
Q4
Sell
-3,316
Closed -$1.23M 9017
2014
Q3
$1.23M Sell
3,316
-19,794
-86% -$6.77M ﹤0.01% 3455
2014
Q2
$11.2M Buy
23,110
+23,078
+72,119% +$12.3M 0.01% 1184
2014
Q1
$23K Buy
+32
New +$27.5K ﹤0.01% 7239

Other funds holding OIBR.C

Citadel Advisors's OIBR.C Position: Q1 2020 in Review

Citadel Advisors sold out of OI S.A. American Depositary Shares, each representing five shares of common stock (OIBR.C) in Q1 2020, closing a stake of 35,768 shares — an estimated $33K sold.

Citadel Advisors first reported a position in OIBR.C in Q1 2014 and held it in 8 quarters. The position peaked at $44.3M in Q3 2018. 50 funds tracked by Wall St. Rank hold OIBR.C as of Q1 2020.

  • Citadel Advisors reported no remaining OI S.A. American Depositary Shares, each representing five shares of common stock position as of Q1 2020 after selling out during the quarter.
  • Citadel Advisors sold 35,768 OI S.A. American Depositary Shares, each representing five shares of common stock shares in Q1 2020, an estimated $33K.
  • Citadel Advisors first reported a position in OI S.A. American Depositary Shares, each representing five shares of common stock in Q1 2014 and held it in 8 quarters.
  • Citadel Advisors's OI S.A. American Depositary Shares, each representing five shares of common stock position peaked at $44.3M in Q3 2018.
  • 50 funds tracked by Wall St. Rank held OI S.A. American Depositary Shares, each representing five shares of common stock as of Q1 2020.

Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.